Академический Документы
Профессиональный Документы
Культура Документы
Important facts
___________________________
• Sleep disorders are common
• Sleep disorders are serious
• Sleep disorders are treatable
• Sleep disorders are under diagnosed
2
Important facts
___________________________
• Sleep complaints are usually not due to
psychiatric conditions or character flaws
• Most sleep disorders are readily
diagnosable and treatable
• The studies include
– Polysomnography (PSG)
– Multiple sleep latency test (MSLT)
– Actigraphy
3
Wake System
___________________________
4
Sleep System
___________________________
5
Sleep Wake Cycle
___________________________
6
Changes in sleep with age
___________________________
Stages of sleep
___________________________
1. NREM Sleep
A. Stage 1
B. Stage 2
C. Stage 3
D. Stage 4
2. REM Sleep
8
Sleep Stages
___________________________
Wake
2/3 of life
9
Sleep disorders (ICSD 2)
___________________________
1. Insomnia.
2. Sleep Related Breathing Disorders.
3. Hypersomnia.
4. Cicadian Rhythm Sleep Disorder.
5. Parasomnia.
6. Sleep related Movement Disorder.
10
Insomnia - definition
___________________________
• Insomnia and excessive daytime sleepiness
are primary complaints regardless of the
stage of the disease
• Insomnia includes difficulty falling asleep,
difficulty staying asleep, and early morning
awakening
Insomnia - definition
___________________________
• Insomnia is not defined by the number of
hours of sleep, but rather, by an individual„s
ability to sleep long enough to feel healthy
and alert during the day.
14
Evolution of Insomnia
15
Possible causes of insomnia
___________________________
Headache Abdominal pains
Bad or vivid dreams Fever/night sweats
Problems of breathing Leg cramps
Chest pain/heartburn Fear/anxiety
Need to pass urine or Depression
move bowels
Insomnia
___________________________
1. A complaint of difficulty in initiating,
maintaining or waking up too early or
sleep that is non-restorative or poor in
quality.
2. The above sleep difficulty occurs despite
adequate opportunity and circumstance
for sleep.
3. Insomnia is a symptom – not a disease
per se
17
Insomnia – associated features
___________________________
At least one (or more) of the following
• Fatigue or malaise
• Attention, concentration impairment
• Social/ vocational dysfunction/ poor work
• Mood disturbance or irritability
• Daytime sleepiness
18
Insomnia – resultant problems
___________________________
• Reduction in motivation, energy or initiative
• Proneness for errors or accidents at work
or while driving
• Tension, headaches or gastrointestinal
symptoms in response to sleep loss
• Concerns or worries about sleep
• Secondary psychiatric problems
19
Insomnia - subdivisions
___________________________
• Sleep onset insomnia
• Sleep maintenance insomnia
• Sleep offset insomnia
• Non restorative sleep
21
Types of insomnia
________________________
• Transient insomnia
– < 4 weeks triggered by excitement or stress,
occurs when away from home
• Short-term
– 4 wks to 6 mons , ongoing stress at home or
work, medical problems, psychiatric illness
• Chronic
– Poor sleep every night or most nights for > 6
months, psychological factors (prevalence 9%)
Medical problems
__________________________
• Depression
• Hyperthyroidism
• Arthritis, chronic pain
• Benign prostatic hypertrophy
• Headaches; Sleep apnoea
• Periodic leg movement,
• Restless leg syndrome (RLS)
23
Other problems
__________________________
• Caffeine
• Nicotine
• Alcohol
• Exercise
• Noise
• Light
• Hunger
24
Management of insomnia
____________________________
• Good Sleep History
• Rule out primary psychiatric disorders
• Rule out adverse effects of medications
• Sleep Diary
• Good Sleep Hygiene Measures
• Interventions – CB therapy, medications
25
Management of insomnia
___________________________
• Treat underlying causes whenever possible
• Advise patient to avoid exercise, heavy
meals, alcohol, or conflict situations just
before bed
• Plain aspirin or paracetamol in low doses
may be helpful; or give short-acting
hypnotics or a sedative
• Treat underlying depression
Management of insomnia
___________________________
• Treat underlying Medical Condition
• Treat underlying Psychiatric Condition
• Improve sleep hygiene
• Change environment
• CBT: „primary insomnias‟, transient insomnia
• Pharmacological
• Light, melatonin, or „chronotherapy‟ for
circadian disorders
Medications and insomnia
___________________________
Type of medication Example
29
Non pharmacological treatments
30
Bed room
__________________________
• Temperature
• Fresh air
• S&S
• Comfortable bed
31
Stimulus control
__________________________
• Go to bed when sleepy
• Only S & S in bedroom
• Get up the same time every morning
• Get up when sleep onset does not occur
in 20 min, and go to another room
• No daytime napping
32
Sleep hygiene
__________________________
• Behaviours that interfere with sleep
• Caffeine
• Alcohol
• Nicotine
• Daytime napping
• Exercise < 4hrs before bed
33
Relaxation training
__________________________
• Progressive muscle relaxation
• Diaphragmatic breathing
• Autogenic training
• Biofeedback
• Meditation, Yoga
• Hypnosis to ↓ anxiety & tension at bedtime
34
Thought stopping
__________________________
• Interrupt unwanted pre-sleep cognitive
activity by instructing patient to repeat
sub-vocally „the‟ every 3 sec
(articulatory suppression)
35
Behavioural therapies
__________________________
• Explicit instruction to stay awake when they go to bed;
Aim is to reduce anxiety associated with trying to fall
asleep – Paradoxical intention
• Alter irrational beliefs about sleep, provide accurate
information that counteracts false beliefs – Cognitive
restructuring
• Patient imagines 6 common objects (candle, kite, fruit,
hourglass, blackboard, light bulb) emphasis on
imagining shape, colour, texture – Imagery training
36
Benzodiazepine receptor agonists
__________________________
• Benzodiazepines • Non Benzodiazepines
– Lorazepam – Zolpidem
– Clonezepam – Zolpidem CR
– Temazepam – Zeleplon
– Flurazepam – Eszopiclone
– Quazepam
• Both these classes act
– Alprazolam on the GABAA receptors
– Triazolam (BzRA) in PCN
– Estazolam
37
Other classes of medications
__________________________
• Antidepressants • Melatonin Receptor Agonists
– Trazadone – Melatonin
– Mirtazapine – Ramelteon
– Doxepin
• Miscellaneous
– Amitryptyline
– Valerian
• Antipsychotics – Diphenhydramine
– Olanzapine – Cyclobenzaprine
– Quitiepine – Hydroxyzine
– Alcohol
38
BzRAs – side effects and safety
__________________________
• Anterograde amnesia
• Residual sedation – longer acting BzRAs
• Rebound Insomnia?
• Abuse and dependence?
– Mostly used short term (2 weeks)
– When used as a sleeping aid dose escalation rare
– No physical dependence with night time use
– Low psychological dependence with night time use
• Increased fall risk, cognitive effects in the elderly
Benzodiazepines
____________________________
• Benzodiazepines (GABA receptor agonist)
• Transient insomnia, (max 2 wks, ideally 2-3/wk)
– Long ½ life - nitrazepam
– Medium ½ life - temazepam
– Short ½ life - diazepam
– Poor functional day time status, cognitive impairment,
daytime sleepiness, falls and accidents, depression
– Acute withdrawal, confusion, psychosis, fits - may
occur up to 3/52 from stopping
40
Benzodiazepine use
____________________________
• Benzodiazepines are the drugs of choice for the
treatment of insomnia.
• Flurazepam can be used for up to one month
with little tolerance.
• Temazepam can be used for up to three
months with little tolerance.
• Intermittent use recommended (every three
days). Use for no longer than 3 – 6 months.
Benzodiazepine use
____________________________
• Half-life is an important factor
• Benzodiazepines with long half lives (e.g.,
flurazepam) produce sustained sleep, but
increased risk of daytime somnolence
• Benzodiazepines with short half lives may be
best for patients with difficulty falling asleep, but
can produce rebound insomnia
• Development of tolerance can produce rebound
insomnia in compounds with short half lives
Benzodiazepine abuse
____________________________
• Benzodiazepines have relatively low
abuse potential.
• Prolonged use can lead to withdrawal
symptoms: headache, irritability,
dizziness, abnormal sleep
• Rebound insomnia - triazolam
Benzodiazepine toxicity
____________________________
• Low toxicity when taken alone
• In combination can be fatal
• Flumanzenil is a benzodiazepine
antagonist that can be used to block
adverse effects of benzodiazepines
• Stomach pump, charcoal, hemodialysis
Non benzodiazepines
____________________________
• Act at the benzodiazepine receptor
• Less risk of dependence
• Zaleplon short ½ life
• Zolipidem, Zopiclone slightly longer ½ life
• No difference in effectiveness & safety
• More expensive
• Only to be used if adverse effects to BZP
45
Zolpidem
____________________________
• Short half life
53
THANK YOU ALL
54